AU6367096A - Use of ipriflavone to reduce the number of cd8+ cells - Google Patents

Use of ipriflavone to reduce the number of cd8+ cells

Info

Publication number
AU6367096A
AU6367096A AU63670/96A AU6367096A AU6367096A AU 6367096 A AU6367096 A AU 6367096A AU 63670/96 A AU63670/96 A AU 63670/96A AU 6367096 A AU6367096 A AU 6367096A AU 6367096 A AU6367096 A AU 6367096A
Authority
AU
Australia
Prior art keywords
ipriflavone
cells
reduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63670/96A
Other languages
English (en)
Inventor
Peter Aranyi
Terezia Kerepesi
Attila B. Kovacs
Attila Tar
Gyorgy Varai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of AU6367096A publication Critical patent/AU6367096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
AU63670/96A 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells Abandoned AU6367096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9502198 1995-07-21
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Publications (1)

Publication Number Publication Date
AU6367096A true AU6367096A (en) 1997-02-18

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63670/96A Abandoned AU6367096A (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Country Status (22)

Country Link
EP (1) EP0841915A1 (hr)
JP (1) JP2001503371A (hr)
KR (1) KR19990028933A (hr)
CN (1) CN1191483A (hr)
AR (1) AR002905A1 (hr)
AU (1) AU6367096A (hr)
BG (1) BG102182A (hr)
BR (1) BR9610187A (hr)
CA (1) CA2227421A1 (hr)
CZ (1) CZ2798A3 (hr)
EA (1) EA199800146A1 (hr)
EE (1) EE9800020A (hr)
HR (1) HRP960345A2 (hr)
HU (1) HU9502198D0 (hr)
IL (1) IL122751A0 (hr)
MX (1) MX9800603A (hr)
NO (1) NO980127L (hr)
PL (1) PL324460A1 (hr)
SK (1) SK3298A3 (hr)
WO (1) WO1997003664A1 (hr)
YU (1) YU42796A (hr)
ZA (1) ZA966079B (hr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
HRP960345A2 (en) 1998-02-28
IL122751A0 (en) 1998-08-16
EE9800020A (et) 1998-08-17
BG102182A (en) 1998-08-31
NO980127D0 (no) 1998-01-12
EP0841915A1 (en) 1998-05-20
HU9502198D0 (en) 1995-09-28
PL324460A1 (en) 1998-05-25
CZ2798A3 (cs) 1998-06-17
MX9800603A (es) 1998-04-30
KR19990028933A (ko) 1999-04-15
AR002905A1 (es) 1998-04-29
SK3298A3 (en) 1998-07-08
JP2001503371A (ja) 2001-03-13
NO980127L (no) 1998-01-12
EA199800146A1 (ru) 1998-08-27
CN1191483A (zh) 1998-08-26
YU42796A (sh) 1999-03-04
WO1997003664A8 (en) 1999-08-05
WO1997003664A1 (en) 1997-02-06
CA2227421A1 (en) 1997-02-06
ZA966079B (en) 1998-01-19
BR9610187A (pt) 1998-07-28

Similar Documents

Publication Publication Date Title
AU7612196A (en) Functional human hematopoietic cells
AU6988596A (en) Photovoltaic cell
AU4702593A (en) Photovoltaic cell
AU6792187A (en) Polymerisable compositions
AU6703094A (en) Use of flavonoids to treat multidrug resistant cancer cells
AU3752293A (en) Photovoltaic cells
AU3959393A (en) Improvements relating to the protection of corrosion-susceptible members
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU6367096A (en) Use of ipriflavone to reduce the number of cd8+ cells
AU6133196A (en) Improvements relating to sighting devices
AU7254994A (en) Alcohol to azide sn2 conversion
AU6127096A (en) Solar geo-stellar planisphere
AU4331793A (en) Solar cooker-sterilizer
AU5239896A (en) Conversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines
AU5697394A (en) Photovoltaic cells
GB2305445B (en) Improvements relating to buildings
AUPM282593A0 (en) Supplying electricity to buildings
AUPN247195A0 (en) Improvements to swaybars
AU686090B3 (en) Improvements to headwear
AU7947994A (en) Improvement to electromagnetotherapy apparatuses
AU1431697A (en) Gene which enables cancer cells to return to normal
AUPN151795A0 (en) New way to produce electricity
AU707764C (en) Improvements relating to locating devices
AUPN567095A0 (en) Improvements to chairs
AUPN154595A0 (en) Improvements to headwear

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted